#Medicare #GLP1 #HealthcareNews #PublicHealth #HealthcarePolicy #ObesityCare #DiabetesCare #Healthcare360Magazine To view or add a comment, sign in A new editorial in JAMA raises good questions about the Medicare Bridge program
Patrik Jonsson, EVP of Eli Lilly and president of Lilly International, said in an April 30 earnings call that while the company only has a few weeks worth of data from India on how generic semaglutide is impacting the market, it seems the generics are really stimulating the growth in the overall obesity market, and that includes [Mounjaro]. Prescriptions for Mounjaro have been 10% higher in recent weeks compared to before generic semaglutide was introduced, he added
On August 13th I was 200.6lbs, and on September 3rd the day before flying to visit my parents I weighed 213.4lbs, a shocking weight gain
I found this video interesting
Bernal, W., Auzinger, G., Dhawan, A
by binding to cysteine and histidine residues it stabilizes tertiary protein structure and modulates gene expression via zinc-finger motifs
